Symbol
|
MZPLTQ | P319TQ | P308TQ | NGFLTQ | P322TQ | VDALTQ | VBMLTQ | VXULTQ | WEVLTQ | RMASRV | RMAJLV | WXNLTQ | EOJRCH | RMABXV | ICOEFG | NELRCH | YOTLTQ | NPYRCH | RMBWDV | RMAVSV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Vonti | Multi Vonti | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti |
Basiswert
|
Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / Zurich Insurance Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Swiss RE AG / UBS Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis Sandoz Basket / Roche AG / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS | Nestlé / Novartis / Roche GS / Zurich | Novartis / Roche GS / Swiss Life / Zurich | Nestlé / Novartis / Roche GS | Novartis AG / Sika AG / Swisscom N / Zurich Insurance Group AG | Nestlé / Novartis / Roche GS / UBS / Zurich | Holcim AG / Kühne & Nagel Intl. AG / Nestlé S.A. / Novartis AG / Roche AG |
Emittent
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Fälligkeit
|
07.07.2025 | 08.09.2025 | 07.10.2025 | 07.10.2025 | 23.12.2025 | 16.09.2025 | 30.09.2025 | 11.07.2025 | 31.03.2028 | 10.02.2026 | 10.06.2025 | 30.06.2028 | 14.01.2026 | 12.10.2026 | 03.11.2028 | 03.11.2025 | 24.11.2027 | 02.02.2026 | 27.07.2026 | 23.02.2026 |
Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Ausübungs-Preis
|
58.00 | 58.64 | 54.62 | 54.62 | 66.90 | 53.0604 | 53.41 | 203.76 | 49.63 | 61.33 | 86.32 | 94.1728 | 188.09 | 182.96 | - | 190.20 | 178.20 | 63.7974 | 63.33 | 61.91 |
Maximal- rendite p.a. |
91.41% | 53.61% | 45.83% | 44.38% | 27.71% | 0.47% | 0.09% | 7.50% | 4.62% | 6.36% | 21.49% | 6.18% | 5.20% | 6.38% | - | 2.57% | 4.85% | 6.29% | 8.45% | 16.46% |
Geld | 97.19 | 95.23 | 94.58 | 95.04 | 96.83 | 101.06 | 100.69 | 99.09 | 99.61 | 100.20 | 96.90 | 94.54 | 99.36 | 96.80 | 104.13 | 102.21 | 99.40 | 99.58 | 96.90 | 90.10 |
Brief | 97.99 | 96.03 | 95.38 | 95.84 | 97.63 | 101.87 | 101.50 | 99.89 | 100.41 | 103.00 | 99.90 | 95.34 | 100.16 | 99.80 | - | 103.03 | 100.20 | 100.38 | 99.70 | 91.30 |